Indegene Ltd
INDGNIndegene Ltd
INDGNPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
40.86 | 10.67 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
50.66 | 7.19 | 0.53% |
Forecast & Ratings
Detailed Forecast from 7 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Indegene Limited is a life sciences commercialization company. It provides digital-led commercialization services for the life sciences industry.
Investor Presentation
View olderPeers
Compare with peersOne 97 Communications Ltd
Kfin Technologies Ltd
RITES Ltd
SIS Ltd
Awfis Space Solutions Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 559.83 | 646.91 | 1,033.53 | 1,690.50 | 2,364.10 | 2,759.40 | 2,792.30 | |||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,167.10 | |||||||
Power & Fuel Cost | 2.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
Employee Cost | 367.45 | 369.92 | 535.60 | 1,014.34 | 1,464.80 | 1,651.60 | ||||||||
Selling & Administrative Expenses | 70.79 | 49.55 | 54.82 | 99.74 | 174.90 | 176.30 | ||||||||
Operating & Other expenses | 70.90 | 185.58 | 215.42 | 310.51 | 270.30 | 347.40 | ||||||||
EBITDA | 48.57 | 41.86 | 227.69 | 265.91 | 454.10 | 584.10 | 625.20 | |||||||
Depreciation/Amortization | 16.60 | 19.34 | 25.55 | 33.45 | 59.80 | 76.10 | 75.60 | |||||||
PBIT | 31.97 | 22.52 | 202.14 | 232.46 | 394.30 | 508.00 | 549.60 | |||||||
Interest & Other Items | 6.25 | 8.84 | 6.96 | 5.96 | 31.30 | 49.40 | 40.10 | |||||||
PBT | 25.72 | 13.68 | 195.18 | 226.50 | 363.00 | 458.60 | 509.50 | |||||||
Taxes & Other Items | 11.62 | 20.00 | 45.79 | 61.74 | 96.90 | 121.90 | 136.50 | |||||||
Net Income | 14.10 | -6.32 | 149.39 | 164.76 | 266.10 | 336.70 | 373.00 | |||||||
EPS | 0.71 | -0.32 | 7.57 | 7.87 | 12.03 | 15.18 | 16.80 | |||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
IndustrialsBusiness Support Services
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Indegene Ltd | 45.27 | 10.67 | — |
One 97 Communications Ltd | -42.26 | 4.50 | — |
Kfin Technologies Ltd | 84.71 | 18.27 | 0.47% |
RITES Ltd | 30.38 | 5.08 | 3.13% |
Price Comparison
Compare INDGN with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 1.03%
Shareholding Pattern
Apr 2024
May 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Indegene Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
DSP Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.3095% | Percentage of the fund’s portfolio invested in the stock 0.29% | Change in the portfolio weight of the stock over the last 3 months 0.09% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 76/81 (-5) |
SBI Innovative Opportunities Fund - Direct Plan - Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.2952% | Percentage of the fund’s portfolio invested in the stock 0.58% | Change in the portfolio weight of the stock over the last 3 months 0.58% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 35/39 (-18) |
Helios Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.2032% | Percentage of the fund’s portfolio invested in the stock 1.44% | Change in the portfolio weight of the stock over the last 3 months -0.25% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 40/66 (-4) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
INDGN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Indegene announced a new center in Hyderabad to strengthen its global delivery operations and better address growing business needs. As the pharma industry faces increasing pressure to innovate and adapt, this new center will play a key role in helping companies accelerate their transformation. This move aligns with Indegene's purpose: to enable healthcare organizations to be future-ready by combining deep medical expertise with fit-for purpose technology. Powered by Capital Market - Live
Net profit of Indegene rose 22.27% to Rs 91.70 crore in the quarter ended September 2024 as against Rs 75.00 crore during the previous quarter ended September 2023. Sales rose 8.04% to Rs 686.80 crore in the quarter ended September 2024 as against Rs 635.70 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales686.80635.70 8 OPM %18.3619.05 - PBDT143.50120.40 19 PBT124.10100.60 23 NP91.7075.00 22 Powered by Capital Market - Live
Indegene will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Live
Indegene announced that the 26th Annual General Meeting (AGM) of the company will be held on 6 September 2024.Powered by Capital Market - Live
Net profit of Indegene rose 28.22% to Rs 87.70 crore in the quarter ended June 2024 as against Rs 68.40 crore during the previous quarter ended June 2023. Sales rose 11.36% to Rs 676.50 crore in the quarter ended June 2024 as against Rs 607.50 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales676.50607.50 11 OPM %19.0515.93 - PBDT139.70112.70 24 PBT119.6092.50 29 NP87.7068.40 28 Powered by Capital Market - Live
Indegene will hold a meeting of the Board of Directors of the Company on 1 August 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 37.58%, vs industry avg of 14.16%
Increasing Market Share
Over the last 5 years, market share increased from 3.07% to 6.99%